Q-omics provides the consensus-scored MIR5583-1 profile across patient tissues and cancer cell-line models. MIR5583-1 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, MIR5583-1 RNA expression shows 5,825 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight TGCT, and UCEC as cancer lineages where MIR5583-1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.